Delivery Order SPE2DB20D2014-SPE2DB25FC63V
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DB22D1106) by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,988,102 units of Polyethylene Glycol 3350 Powder in 510-gram quantities. The contract has a ceiling value of $2,830.48 and a period of performance through March 18, 2024. This award is part of a larger indefinite delivery contract (SPE2DB24FEFF7) with DLA valued at up to...
- The U.S. government awarded a $5,513.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a performance period through February 2025, is for the supply of polyethylene glycol medical products to the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, as well as a separate...
- <p>This delivery order, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, is for one hundred seventy-four dollars worth of polyethylene glycol 3350 powder 238gm. The product will be delivered to a location in Conshohocken, Pennsylvania by October 13, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation. No set-aside designation was used for this firm fixed price order.</p>
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $66 firm fixed price delivery order contract to supply 238gm bottles of polyethylene glycol 3350 powder to the Defense Logistics Agency Troop Support Medical. Performance will take place in Conshohocken, Pennsylvania by October 13, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of armed forces personnel by procuring pharmaceuticals and other medical supplies, so...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,657.32 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. AmerisourceBergen Drug Corp, a major healthcare solutions provider and pharmaceutical distributor,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,126.93 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract action for pharmaceutical and medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.36 to AmerisourceBergen Drug Corp on July 29, 2025, under a firm fixed-price contract with an ultimate completion date of July 30, 2025. This non-set-aside award is issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,688.08 to AmerisourceBergen Drug Corp on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical products and medical supplies. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,960.16 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC63VDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,025.15 for Polyethylene Glycol 3350 Powder (238GM) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract carries firm fixed pricing and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables the company to supply a broad range of pharmaceutical products, specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to involve multiple regional awards among several contractors, with AmerisourceBergen positioned as a significant provider under this strategic approach.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/4/25 |